Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.22 USD | +0.32% | +7.99% | -31.80% |
Mar. 20 | Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing | MT |
Mar. 19 | Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance | MT |
Business Summary
Number of employees: 676
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Full Spectrum Flow Cytometry Platform
81.2
%
| 149 | 90.6 % | 157 | 81.2 % | +5.46% |
Service
18.8
%
| 15 | 9.4 % | 36 | 18.8 % | +135.15% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
52.9
%
| 95 | 57.7 % | 102 | 52.9 % | +7.92% |
EMEA
27.6
%
| 44 | 26.8 % | 53 | 27.6 % | +20.97% |
APAC
16.4
%
| 23 | 13.7 % | 32 | 16.4 % | +40.29% |
Other
3.2
%
| 3 | 1.8 % | 6 | 3.2 % | +107.69% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ming Yan
FOU | Founder | 61 | 14-11-30 |
Wen Bin Jiang
FOU | Founder | 60 | 14-11-30 |
Chris Williams
COO | Chief Operating Officer | 55 | 22-10-30 |
Paul Goodson
IRC | Investor Relations Contact | - | - |
Philippe Busque
SAM | Sales & Marketing | - | 23-08-27 |
Connie Wedel
HRO | Human Resources Officer | - | - |
Melik Ulusu
PRN | Corporate Officer/Principal | - | 19-12-31 |
Allen Poirson
PRN | Corporate Officer/Principal | 64 | 18-11-12 |
Valerie Barnett
LAW | General Counsel | 49 | 20-12-31 |
Patrik Jeanmonod
PRN | Corporate Officer/Principal | 58 | 18-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donnie Hardison
BRD | Director/Board Member | 74 | 22-05-31 |
Deborah Neff
BRD | Director/Board Member | 71 | - |
Jack Ball
BRD | Director/Board Member | 77 | 18-11-12 |
Allen Poirson
PRN | Corporate Officer/Principal | 64 | 18-11-12 |
Wen Bin Jiang
FOU | Founder | 60 | 14-11-30 |
Gisele Dion
BRD | Director/Board Member | 57 | 21-02-28 |
Ming Yan
FOU | Founder | 61 | 14-11-30 |
Vera Imper
BRD | Director/Board Member | 62 | 21-12-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 131,264,277 | 119,888,200 ( 91.33 %) | 0 | 91.33 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.80% | 816M | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B | |
+26.14% | 31.88B |
- Stock Market
- Equities
- CTKB Stock
- Company Cytek Biosciences, Inc.